S3861Temporary National Codes (Non-Medicare)
Genetic testing, sodium channel, voltage-gated, type v, alpha subunit (scn5a)
Short description: Genetic test brugada
- Effective date
- October 1, 2008
- Termination date
- —
Related codes (S-series)
S0012Butorphanol tartrate, nasalS0013Esketamine, nasal sprayS0014Tacrine hydrochloride, 10 mgS0017Injection, aminocaproic acidS0020Injection, bupivicaine hydroS0021Injection, cefoperazone sodS0023Injection, cimetidine hydrocS0028Injection, famotidine, 20 mgS0030Injection, metronidazoleS0032Injection, nafcillin sodiumS0034Injection, ofloxacin, 400 mgS0039Injection, sulfamethoxazole
Frequently asked questions
What is HCPCS code S3861?
S3861 is a HCPCS Level II code for Genetic testing, sodium channel, voltage-gated, type v, alpha subunit (scn5a).
What category is HCPCS code S3861 in?
S3861 falls under the Temporary National Codes (Non-Medicare) category of HCPCS Level II.
When did HCPCS code S3861 become effective?
S3861 has been effective since October 1, 2008, per CMS's quarterly HCPCS update.
HCPCS Level II data from CMS (public domain). HCPCS Level I (CPT) codes are not included — CPT is copyrighted by the American Medical Association. Always verify codes with authoritative sources before making coding or billing decisions.